share_log

Hutchmed (China) | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)

和黃醫藥 | SC 13D/A:超過5%持股股東披露文件(修正)

2020/11/27 06:05
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息